Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neuroendocrine Tumors × Phlebotomy × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

NET 1 Endocrine 1

Conditions

Neoplasms 5 Polycythemia Vera 4 Lung Neoplasms 4 Myeloproliferative Disorders 3 Colorectal Neoplasms 3 Breast Neoplasms 3 Prostatic Neoplasms 2 Ovarian Neoplasms 2 Lymphoma 2 Head and Neck Neoplasms 2 Carcinoma, Squamous Cell 2 Carcinoma, Non-Small-Cell Lung 2 Brain Neoplasms 2 Adenocarcinoma 2 Urticaria 1 Tuberous Sclerosis 1 Thymic aplasia 1 Thrombosis 1 Squamous Cell Carcinoma of Head and Neck 1 Smoking 1 Small Cell Lung Carcinoma 1 Severe Combined Immunodeficiency 1 Sarcoma 1 Salivary Gland Neoplasms 1 Renal Insufficiency, Chronic 1 Rectal Neoplasms 1 Primary Dysautonomias 1 Polycythemia 1 Polycystic Ovary Syndrome 1 Pancreatitis, Chronic 1

Interventions

lutetium Lu 177 dotatate 39 Everolimus 31 Magnetic Resonance Spectroscopy 15 lanreotide 13 gallium Ga 68 dotatate 12 Octreotide 12 Temozolomide 11 Capecitabine 11 Nivolumab 10 177Lu-octreotide, DOTA(0)-Tyr(3)- 10 surufatinib 9 pembrolizumab 8 cabozantinib 8 Positron Emission Tomography Computed Tomography 8 3-Iodobenzylguanidine 8 Sunitinib 7 Specimen Handling 7 amino-acid, glucose, and electrolyte solution 6 Somatostatin 6 Lutetium-177 6 90Y-octreotide, DOTA-Tyr(3)- 6 telotristat ethyl 5 pasireotide 5 Ga(III)-DOTATOC 5 Fluorodeoxyglucose F18 5 Carboplatin 5 Bevacizumab 5 olaparib 4 copper dotatate CU-64 4 avelumab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03130205 2017-08-25

PROGRESS

Uppsala University

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡